Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline

Life Sciences

Volumn 81, Issue 6, 2007, Pages 458-467

  Ogunrombi, Modupe O ^a   Malan, Sarel F ^a   Terre'Blanche, Gisella ^a   Castagnoli, Kay ^b   Castagnoli Jr , Neal ^b   Bergh, Jacobus J ^a   Petzer, Jacobus P ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

1 Methyl 3 phenyl 3 pyrroline; 1 Methyl 3 phenylpyrrole; Dopamine; Monoamine oxidase B; MPTP; Neurotoxicity; Striata

Indexed keywords

1 METHYL 3 PHENYL 3 PYRROLINE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; NEUROTOXIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROCHEMISTRY; ENZYME SUBSTRATE; MALE; MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATION KINETICS; PARKINSONISM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BIOTRANSFORMATION; BRAIN; CATTLE; DOPAMINE; DOPAMINE AGENTS; LIVER; MALE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE; MPTP POISONING; NEOSTRIATUM; PAPIO;

PARKINSONIA;

EID: 34547463721     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.06.014     Document Type: Article

References (37)

1. Andrews L.H., and McElvain S.M. Gamma-pyrrolidino- and gamma-pyrrolidinopropyl benzoates. Journal of the American Chemical Society 51 (1929) 887-892
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
3. Castagnoli K., Palmer S., Anderson A., Bueters T., and Castagnoli Jr. N. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chemical Research in Toxicology 10 4 (1997) 364-368
4. Castagnoli K.P., Steyn S.J., Petzer J.P., Van der Schyf C.J., and Castagnoli Jr. N. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. Chemical Research in Toxicology 14 5 (2001) 523-527
5. Chiba K., Trevor A., and Castagnoli Jr. N. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochemical and Biophysical Research Communications 120 2 (1984) 574-578
6. +, a metabolite of MPTP, by brain synaptosomes. Biochemical and Biophysical Research Communications 128 3 (1985) 1228-1232
7. Di Monte D.A., Royland J.E., Anderson A., Castagnoli K., Castagnoli Jr. N., and Langston J.W. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. Journal of Neurochemistry 69 4 (1997) 1771-1773
8. Gallagher P.T., Palmer J.L., and Morgan S.E. A regiospecific synthesis of 3-arylpyrroles. Journal of the Chemical Society. Perkin Transactions 1 11 (1990) 3212-3214
9. Harvey B.H., Brand L., Jeeva Z., and Stein D.J. Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder. Physiology & Behavior 87 5 (2006) 881-890
10. Heikkila R.E., Hess A., and Duvoisin R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224 4656 (1984) 1451-1453
11. Heikkila R.E., Manzino L., Cabbat F.S., and Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311 5985 (1984) 467-469
12. 3-pyrroline. Tetrahedron Letters 41 (1967) 4015-4017
13. Inoue H., Castagnoli K., Van der Schyf C., Mabic S., Igarashi K., and Castagnoli Jr. N. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives. Journal of Pharmacology and Experimental Therapeutics 291 2 (1999) 856-864
14. + by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. European Journal of Pharmacology 106 2 (1984) 455-456
15. Jutz C., Kirchlechner R., and Siedel H.J. Über die umsetzung von phenalen mit vinylogen farmamidinium-salzen: Synthese substituierter pyrene und des azuleno[5,6,7-cd]phenalens. Chemische Berichte 102 (1969) 2301-2318
16. Kalgutkar A.S., and Castagnoli Jr. N. Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors. Journal of Medicinal Chemistry 35 22 (1992) 4165-4174
17. Kuhn R., and Osswald G. Neue synthese von b-pyrrolidonen; Darstellung von dl-g-oxo-prolin, dl-allo-hydroxy-prolin und 4-äthoxy-pyrrol-carbonsäure-(2). Chemische Berichte 89 (1956) 1423-1442
18. Lee Y., Ling K.Q., Lu X., Silverman R.B., Shepard E.M., Dooley D.M., and Sayre L.M. 3-Pyrrolines are mechanism-based inactivators of the quinone-dependent amine oxidases but only substrates of the flavin-dependent amine oxidases. Journal of the American Chemical Society 124 41 (2002) 12135-12143
19. Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., and Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311 5958 (1984) 464-467
20. Nicklas W.J., Vyas I., and Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sciences 36 26 (1985) 2503-2508
21. Perry T.L., Jones K., Hansen S., and Wall R.A. 4-Phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets. Neuroscience Letters 75 1 (1987) 65-70
22. 2A receptor antagonists. Bioorganic & Medicinal Chemistry 11 7 (2003) 1299-1310
23. Pine S.H., and Sanchez B.L. The formic acid-formaldehyde methylation of amines. Journal of Organic Chemistry 36 6 (1971) 829-832
24. Pitts S.M., Markey S.P., Murphy D.L., and Weisz A. Recommended practices for the safe handling of MPTP. In: Markey S.P., Castagnoli Jr. N., Trevor A.J., and Kopin I.J. (Eds). MPTP: A Neurotoxin Producing a Parkinsonian Syndrome (1986), Academic Press, New York 703-716
25. +) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. Journal of Neurochemistry 56 4 (1991) 1184-1190
26. + analogues and related charged species. Journal of Medicinal Chemistry 33 8 (1990) 2221-2230
27. Salach J.I., and Weyler W. Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver. Methods in Enzymology 142 (1987) 627-637
28. Sayre L.M., Singh M.P., Arora P.K., Wang F., McPeak R.J., and Hoppel C.L. Inhibition of mitochondrial respiration by analogues of the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium: structural requirements for accumulation-dependent enhanced inhibitory potency on intact mitochondria. Archives of Biochemistry and Biophysics 280 2 (1990) 274-283
29. Schmidt N., and Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. Journal of Neural Transmission 108 11 (2001) 1263-1282
30. +), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology 49 1 (1988) 17-23
31. Smeyne R.J., and Jackson-Lewis V. The MPTP model of Parkinson's disease. Brain Research. Molecular Brain Research 134 1 (2005) 57-66
32. Takada M., Li Z.K., and Hattori T. Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death. Brain Research 509 1 (1990) 55-61
33. 2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC). Bioorganic & Medicinal Chemistry 14 10 (2006) 3512-3521
34. Wang Y.X., Mabic S., and Castagnoli Jr. N. 1-Methyl-3-pyrrolines and 2-methylisoindolines: new classes of cyclic tertiary amine monoamine oxidase B substrates. Bioorganic & Medicinal Chemistry 6 2 (1998) 143-149
35. 3-pyrrolines. Biochemical Journal 336 Pt 1 (1998) 63-67
36. Williams C.H., and Lawson J. The behaviour of aryl pyrrolines with monoamine oxidase. Neurobiology (Budapest) 7 (1999) 225-233
37. Wu Y.H., Gould W.A., Lobeck Jr. W.G., Roth H.R., and Feldkamp R.F. Pyrrolidines. VII. 3-Hydroxy-1-pyrrolidinecarboxylic acid esters. Journal of Medicinal and Pharmaceutical Chemistry 5 (1962) 752-762